• Company Type For Profit
  • Contact Email waltersmith@confluencelifesciences.com
  • Phone Number (314) 932-4032

CLS is a drug discovery company focusing on rational drug design to discover and develop mechanistically novel kinase inhibitors for use in both human and animal health care. CLS’s kinase inhibitors target key signal transduction enzymes involved in the regulation of cancer growth and survival, or in the modulation of chronic inflammation. Unlike

many other kinase inhibitor programs, however, CLS is targeting novel binding sites (on kinase targets that have proved challenging) as well as previously “un-drugged” kinases. Driving CLS success in this effort is a team of world-class experts with extensive Pharma experience in kinase inhibitor discovery and development. CLS provides this team with the opportunity to pursue strategies and targets outside Pharma’s traditional focus. In addition, scientific and business collaborations are being established to enable the success of the business. The strategy is to develop and maintain a program pipeline: discover, develop, partner, repeat.

Lists Featuring This Company

Missouri Acquired Companies
809 Number of Organizations • $7.6B Total Funding Amount • 297 Number of Investors
Midwestern US Companies that Exited (Top 10K)
9,841 Number of Organizations • $322.5B Total Funding Amount • 6,207 Number of Investors
BioGenerator Portfolio Companies
57 Number of Organizations • $1.2B Total Funding Amount • 353 Number of Investors
Health Care Acquired Companies With Less Than $50M in Revenue
3,437 Number of Organizations • $69.1B Total Funding Amount • 7,182 Number of Investors
Confluence Life Sciences was acquired by Aclaris Therapeutics for $100M on Aug 8, 2017. This deal was done in Cash.

Frequently Asked Questions

Where is Confluence Life Sciences's headquarters? Confluence Life Sciences is located in St Louis, Missouri, United States.Who invested in Confluence Life Sciences? Confluence Life Sciences has 6 investors including Epidarex Capital and St. Louis Arch Angels.How much funding has Confluence Life Sciences raised to date? Confluence Life Sciences has raised .When was the last funding round for Confluence Life Sciences? Confluence Life Sciences closed its last funding round on Apr 20, 2016 from a Venture - Series Unknown round.Who are Confluence Life Sciences's competitors? Alternatives and possible competitors to Confluence Life Sciences may include Novellus.